A detailed history of Y Intercept (Hong Kong) LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 12,724 shares of BDX stock, worth $2.9 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
12,724
Previous 15,425 17.51%
Holding current value
$2.9 Million
Previous $3.6 Million 14.9%
% of portfolio
0.19%
Previous 0.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$221.47 - $242.41 $598,190 - $654,749
-2,701 Reduced 17.51%
12,724 $3.07 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $2.17 Million - $2.37 Million
9,641 Added 166.68%
15,425 $3.6 Million
Q1 2024

May 10, 2024

BUY
$233.45 - $247.73 $1.35 Million - $1.43 Million
5,784 New
5,784 $1.43 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $1.77 Million - $1.97 Million
6,940 New
6,940 $1.79 Million
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $2.58 Million - $3.04 Million
-11,819 Closed
0 $0
Q3 2022

Feb 14, 2023

BUY
$51.03 - $264.23 $603,123 - $3.12 Million
11,819 New
11,819 $2.63 Million
Q2 2022

Aug 08, 2022

SELL
$234.74 - $275.42 $680,041 - $797,891
-2,897 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $449,759 - $499,306
1,846 Added 175.64%
2,897 $771,000
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $894,551 - $975,654
-3,888 Reduced 78.72%
1,051 $264,000
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $456,596 - $503,194
1,962 Added 65.91%
4,939 $1.21 Million
Q2 2021

Aug 26, 2021

BUY
$232.65 - $254.58 $692,599 - $757,884
2,977 New
2,977 $724,000
Q2 2021

Aug 12, 2021

BUY
$232.65 - $254.58 $0 - $0
0 New
0 $724,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.